Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine versus dexmedetomidine for postoperative pain after total laparoscopic hysterectomy
IRCT20190127042511N3Phase 3Recruiting
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketamine and dexmedetomidine in postoperative pain (3 arms), sponsored by Shahrekord University of Medical Sciences. Primary endpoint: Postoperative pain intensity. Started Jun 2026; status: recruiting.
02
Drugs
ketaminedexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20190127042511N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190127042511N3.